Screener / SEC EDGAR /CIK 0001307954 /10-K filed Feb 18, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Chemicals & Allied Products

Huntsman CORP HUN

Compare with peers Embed
SEC comment letters, last 20 years

4 reviews of HUN's filings by SEC staff

UPLOAD and CORRESP
Reviews 4 latest letter May 2, 2025
Questions asked 11 each answered in the company's own letter
No closing letter 1 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 4 UPLOAD
  2. 2. Questions in them 11 numbered comments
  3. 3. Company replies 3 CORRESP
  4. 4. Reviews closed 3 of 4 closing letter

Half the closed reviews took 22 days or less from the first letter to the closing letter.

Form 10-K for the Fiscal Year Ended December 31, 2024

2025-05-02 to 2025-05-22 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2025-05-22
SegmentsNon-GAAP measures
SEC asked (2)
We see that you present and discuss "Adjusted EBITDA from Corporate" for Huntsman Corporation and Huntsman International. Since "Corporate" does not appear to be an operating segment under ASC 280, the presentation of adjusted EBITDA from Corporate appears to be a non-GAAP measure that has not been reconciled to its most directly comparable GAAP measure.
Rest of the question

Please remove from future filings or revise to provide all of the disclosures required by Item 10(e)(1)(i) of Regulation S-K.

HUN answered
and confirm that we will exclude the presentation and discussion of adjusted EBITDA from “Corporate and other” from our MD&A in future filings beginning with our Form 10-Q for the period ending June 30, 2025.
Read in the reply
In its next report

First report after the company's reply of May 15, 2025: 10-Q filed Aug 1, 2025 ↗, against the 10-Q filed May 2, 2025 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Financial Statements · Note 26. Operating Segment Information, page F-49
SEC asked (3)
Revise future filings to provide more substantive disclosure of how the chief operating decision maker uses the reported measure of segment profit or loss in assessing segment performance and deciding how to allocate resources in accordance with ASC 280-10-50-29(f).
Rest of the question

As a related matter, tell us what you mean by the statement in footnote (5) on page F-53 that you "believe that segment adjusted EBITDA more accurately reflects what our CODM, who has been determined to be our Chief Executive Officer, uses to make decisions about resources to be allocated to the segments and assess their financial performance."

HUN answered
and confirm that we will include in our future filings, beginning with our Form 10-Q for the period ending June 30, 2025, further disclosure explaining how our CODM evaluates segment adjusted EBITDA, our reported measure of profit or loss, which includes evaluation through the annual budget process as well as through ongoing periodic reviews of forecasts, budget-to-actual variances, changes from prior periods and when comparing the results of each reportable operating segment with one another.
Rest of the answer

We will also revise the statement in footnote

(5) on page F-53 to state that: “Segment adjusted EBITDA is the measure that our CODM, who has been determined to be our

Chief Executive Officer, uses to make decisions about resources to be allocated to the segments and assess their financial performance.”

Read in the reply
In its next report

First report after the company's reply of May 15, 2025: 10-Q filed Aug 1, 2025 ↗, against the 10-Q filed May 2, 2025 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Consolidated Financial Statements · Note 26. Operating Segment Information, page F-49
SEC asked (4)
Reference footnote (3) and (4) for adjusted fixed costs and other segment items which refer to footnote (5) and indicate that the line items exclude "certain" of those adjustments. In future filings, please revise to disclose the specific adjustments that are excluded from significant segment expenses and other segment items.
Rest of the question

In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

HUN answered
and confirm that, as reflected below, we will include in our future filings in footnotes (3) and (4) of the table appearing on page F-53, beginning with our Form 10-Q for the period ending June 30, 2025, further disclosure of the specific adjustments, applicable for the periods presented, that were excluded from adjusted fixed costs and other segment items, which include business acquisition and integration expenses and purchase accounting inventory adjustments, net; certain legal and other settlements and related expenses;

amortization of pension and postretirement actuarial losses; and
Rest of the answer

restructuring, impairment and plant closing and transition costs.

(3)

Adjusted fixed costs primarily include personnel and maintenance costs at our manufacturing facilities, selling, general and administrative expenses and research and development expenses, less depreciation and amortization and an adjustment to remove the related effects of restructuring, impairment and plant closing and transition costs.

(4)

Other segment items include other operating and non-operating income and expense items and foreign currency exchange effects, less adjustments to remove the related effects of primarily the following items: business acquisition and integration expenses and purchase accounting inventory adjustments, net; certain legal and other settlements and related expenses; amortization of pension and postretirement actuarial losses; and restructuring, impairment and plant closing and transition costs.

Read in the reply
In its next report

First report after the company's reply of May 15, 2025: 10-Q filed Aug 1, 2025 ↗, against the 10-Q filed May 2, 2025 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2025-05-22

Huntsman CORP. · PREC14A filed January 20, 2022 · Filed by Starboard Value LP, et. al. · File No. 001-32427

2022-01-27 to 2022-01-27 · 4 questions · 1 letter from the SEC, 0 from the company
No closing letter
SEC letter of Jan 27, 2022 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Preliminary Proxy Statement filed by Starboard Value LP · Cover Page
SEC asked (1)
Please revise your disclosure to remove references to the annual meeting being held virtually, as the company has not yet made any public statement in this respect. Reasons for the Solicitation, page 8
HUN answered

No reply letter found.

Preliminary Proxy Statement filed by Starboard Value LP · Cover Page
SEC asked (2)
Each statement or assertion of opinion or belief must be clearly characterized as such, and a reasonable factual basis must exist for each such opinion or belief. Support for opinions or beliefs should be self-evident, disclosed in the proxy statement or provided to the staff on a supplemental basis.
Rest of the question

Thus, please provide us support for your disclosures that "[o]ver the past seventeen years as a publicly-traded entity, the Company’s key management and Board leadership roles have remained largely unchanged" (page 8) and that the company's new "nominees were ...also supportive of straying from governance best practices" (page 13).

HUN answered

No reply letter found.

Proposal No. 1 Election of Directors, page 14
SEC asked (3)
We note your references to your nominees' potential inability to "implement any actions that they may believe are necessary to enhance stockholder value" given their minority status. Please revise your disclosure to describe any plans you or your nominees have for the company.
HUN answered

No reply letter found.

Quorum; Broker non-votes; Discretionary Voting, page 23
SEC asked (4)
Please provide us your written analysis for your conclusion that brokers have discretionary authority to vote on proposal 3.
HUN answered

No reply letter found.

Form 10-K for the Fiscal Year Ended December 31, 2020

2021-12-29 to 2022-01-20 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2022-01-20
Non-GAAP measuresIncome taxesResults discussion (MD&A)Segments
Item 7. Management's Discussion and Analysis of financial Condition and Results of Operations · Outlook, page 30
SEC asked (1)
Please address the following regarding your presentation of adjusted tax rate: • At the bottom of page 30, you present adjusted effective tax rate as 19% without presenting the actual effective rate or providing a reconciliation. Please revise accordingly to comply with Item 10(e). • You also disclose that your forecasted adjusted effective tax rate for 201 is expected to be approximately 22% to 24%.
Rest of the question

We note your disclosure on page 35 that you are unable to provide accurate calculations or estimations of reconciling items. Tell us how you determined it was appropriate to present the forecasted adjusted effective tax rate without presenting the forecasted actual effective tax rate for the period in question. Further, tell us how you determined your presentation was appropriate if you are unable to provide accurate calculations or estimations of the reconciling items.

HUN answered
We respectfully acknowledge the Staff’s comment, and we will ensure that our future filings include the presentation of our effective tax rate when we present our adjusted effective tax rate for historical periods.

comment regarding the disclosure of our 2021 forecasted adjusted effective tax rate. Our forecasted adjusted effective tax rate is calculated based on our forecasted effective tax rate and, as of the filing of our Form 10-K, the approximately 22% to 24% range of our forecasted adjusted effective tax rate equaled the range of our forecasted effective tax rate.
Rest of the answer

Our decision to disclose the forecasted adjusted effective tax rate range of approximately 22% to 24% was based upon a recognition that we could not adequately forecast certain one-time items and events that had not yet occurred as of the time of such disclosure that would impact our forecasted effective tax rate (“adjustments”), such as:

· business acquisition and integration expenses,

· purchase accounting inventory adjustments,

· merger costs,

· certain legal and other settlements and related expenses,

· gains on sale of businesses/assets, and tax only items, including tax law changes not yet enacted and, therefore, disclosing a forecasted effective tax rate could confuse a reader, and lead such reader to understand that such items were contemplated for the upcoming year and that we had taken them into account in a forecasted effective tax rate. This reinforces our belief that the forecasted adjusted effective tax rate is a meaningful measure to improve comparability between periods through the exclusion of these items that management believes are not indicative of the businesses’ operational profitability and may obscure underlying business results and trends.

In future filings, we will include an explanation similar to the response above so that readers will more clearly understand that the disclosed forecasted adjusted effective tax rate, in our view, represents the forecasted effective tax rate on our underlying business operations, but does not reflect any of the types of adjustments that might occur in the upcoming year that could cause our effective tax rate to differ.

Read in the reply
In its next report

First report after the company's reply of Jan 7, 2022: 10-K filed Feb 15, 2022 ↗, against the 10-K filed Feb 12, 2021 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Notes to Consolidated Financial Statements · Note 27. Operating Segment Information, page F-61
SEC asked (2)
Your presentation of Total Segment Adjusted EBITDA does not comply with ASC 28010-50-30(b) as the inclusion of 'Corporate and other' does not represent the total of the reportable segments' measure of profit or loss. As such, Total Segment Adjusted EBITDA would represent a non-GAAP measure which is specifically prohibited in your financial statement footnotes by Item 10(e)(1)(ii)(c) of Regulation S-K.
Rest of the question

Furthermore, the total of your reportable segments' measure of profit or loss should be reconciled to consolidated net income/(loss) before income taxes. Accordingly, please revise your presentation of your reportable segments' measure of profit or loss and the accompanying reconciliations as well as your discussion of Non-GAAP Financial Measures on page 34. This applies to your Form 10-Q for the quarter ended September 30, 2021 and your press release furnished as exhibit 99.1 to your Form 8-K filed October 29, 2021 as well. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

HUN answered
comment regarding our presentation of Total Segment Adjusted EBITDA and the reconciliation of the total of our reportable segments’ measure of profit or loss to consolidated income before income taxes and discontinued operations. As requested and as reflected below, we intend to revise our presentation of the total of our reportable segments’ measure of profit or loss and the accompanying reconciliations in our Operating Segment Information footnote and will provide this revised footnote presentation in our Form 10-K filing for the fiscal year ended December 31, 2021 along with this
Rest of the answer

additional disclosure: “We have revised our prior years’ presentation below to reconcile total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes in addition to net income, and removed “corporate and other costs, net” from the total reportable segments’ adjusted EBITDA and included such amounts in the reconciliation to income from continuing operations before income taxes.”

Year ended

December 31,

2020

2019

2018

Huntsman Corporation:

Segment adjusted EBITDA(1):

Polyurethanes

$ 472

$ 548

$ 809

Performance Products

164

168

197

Advanced Materials

130

201

225

Textile Effects

101

Total reportable segments’ adjusted EBITDA

808

1,001

1,332

Reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes:

Interest expense, net—continuing operations

(86 )

(111 )

(115 )

Depreciation and amortization—continuing operations

(283 )

(270 )

(255 )

Corporate and other costs, net(2)

(161 )

(155 )

(171 )

Net income attributable to noncontrolling interests

Other adjustments:

Business acquisition and integration expenses and purchase accounting inventory adjustments

(31 )

(5 )

(9 )

Merger costs

—

(2 )

Fair value adjustments to Venator investment and related loss on disposal

(88 )

(18 )

(62 )

Loss on early extinguishment of debt

(23 )

(3 )

Certain legal and other settlements and related expenses

(6 )

(1 )

Gain (loss) on sale of businesses/assets

280

(21 )

Income from transition services arrangements

Certain nonrecurring information technology project implementation costs

(4 )

Amortization of pension and postretirement actuarial losses

(76 )

(66 )

(67 )

Plant incident remediation costs

(8 )

Restructuring, impairment and plant closing and transition (costs) credits

(52 )

Income from continuing operations before income taxes

337

391

734

Income tax (expense) benefit—continuing operations

(46 )

(45 )

Income (loss) from discontinued operations, net of tax

775

169

(39 )

Net income

$ 1,066

$ 598

$ 650

Huntsman International:

Total reportable segments’ adjusted

EBITDA

(126 )

(136 )

(252 )

(150 )

(167 )

Loss on early extinguishment of debt

(79 )

(70 )

(71 )

Income from continuing operations before income taxes

338

377

716

(41 )

Income (loss) from discontinued operations, net of tax

$ 1,067

$ 587

$ 636

(1)

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) merger costs; (c) fair value adjustments to Venator investment and related loss on disposal; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related expenses; (f) gain (loss) on sale of businesses/assets; (g) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; (h) certain nonrecurring information technology project implementation costs; (i) amortization of pension and postretirement actuarial losses; (j) plant incident remediation costs; (k) restructuring, impairment, plant closing and transition (costs) credits; and (l) income (loss) from discontinued operations, net of tax.

(2)

Corporate and other costs, net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, nonoperating income and expense and gains and losses on the disposition of corporate assets.

We also intend to revise our presentation of the total of our reportable segments’ adjusted EBITDA in our Segment Analysis within Management’s Discussion and Analysis of

Financial Condition and Results of Operations to conform to the changes made in Footnote 27, Operating Segment Information, and will provide this revised presentation reflected below in our Form 10-K for the year ended December 31, 2021 and future Form 10-Q filings as well as in our future earnings releases furnished as exhibits to our future Form 8-K filings.

Percent

Change

Favorable

(Dollars in millions)

(Unfavorable)

Huntsman Corporation

Adjusted

EBITDA(1)

(14 )%

(2 )%

(35 )%

(50 )%

(19 )%

Corporate and other

(4 )%

Total adjusted EBITDA

$ 647

$ 846

(24 )%

Huntsman International

(3 )%

$ 653

$ 851

(23 )%

NM—Not meaningful

For more information, including reconciliation of total reportable segments’ adjusted EBITDA to income from continuing operations before income taxes of Huntsman Corporation or Huntsman International, as appropriate, see “Note 27. Operating Segment

Information” to our consolidated financial statements.

total of our reportable segments’ measure of profit or loss and the accompanying reconciliations in our Operating Segment Information, as reflected below, and will provide this revised footnote presentation in future Form 10-Q filings beginning with our Form 10-Q for the quarter ended March 31, 2022. We will include disclosures in each of our Form 10-Q filings for the 2022 fiscal year similar to that noted above in our Form 10-K for the fiscal year ended December 31, 2021 to address the revisions that have been made to prior year’s presentation.

Three months

Nine months ended

September 30,

2021

$ 246

$ 156

$ 661

$ 271

103

254

123

150

419

1,140

521 of total reportable segments’ adjusted EBITDA to income (loss) from continuing operations before income taxes:

(15 )

(24 )

(63 )

(72 )

(219 )

(206 )

(48 )

(37 )

(146 )

(114 )

(19 )

(30 )

(28 )

(100 )

(27 ) and related income (expenses)

(10 )

Gain on sale of businesses/assets

(22 )

(20 )

(65 )

(57 ) impairment and plant closing and transition costs

(12 )

(36 )

(34 )

Income (loss) from continuing operations before income taxes

268

614

Income tax expense—continuing operations

(38 )

(Loss) income from discontinued operations, net of tax(3)

782

$ 225

$ 57

$ 497

$ 706

Reconciliation of total reportable segments’ adjusted EBITDA to income (loss) from continuing operations before income taxes:

(47 )

(140 )

(110 )

(59 )

269

618

$ 58

$ 500

We use segment adjusted EBITDA as the measure of each segment’s profit or loss. We believe that segment adjusted EBITDA more accurately reflects what the chief operating decision maker uses to make decisions about resources to be allocated to the segments and assess their financial performance. Segment adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) fair value adjustments to Venator investment; (c) loss on early extinguishment of debt; (d) certain legal and other settlements and related income (expenses); (e) gain on sale of businesses/assets; (f) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; (g) certain nonrecurring information technology project implementation costs; (h) amortization of pension and postretirement actuarial losses; (i) plant incident remediation costs; (j) restructuring, impairment, plant closing and transition costs; and (k) (loss) income from discontinued operations, net of tax.

and other costs, net includes unallocated corporate overhead, unallocated foreign exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets.

(3)

Includes the gain on the sale of our Chemical Intermediates Businesses in 2020.

Read in the reply
In its next report

First report after the company's reply of Jan 7, 2022: 10-K filed Feb 15, 2022 ↗, against the 10-K filed Feb 12, 2021 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2022-01-20

Form 10-K for the Fiscal Year Ended December 31, 2018

2019-07-26 to 2019-08-29 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2019-08-29
Results discussion (MD&A)
Note 4. Discontinued Operations and Business Disposition, page F-27
SEC asked (1)
We note that notwithstanding your remaining 49% interest in Venator, you continue to reflect this business as discontinued operations. Please tell us how you considered the nature, time frame and extent of this continuing involvement in Venator in your determination that the disposition of your 51% interest resulted in a strategic shift that has had (or will have) a major effect on your results of operations and
Rest of the question

financial results such that this disposition qualified for discontinued operations presentation. Refer to ASC 20520-45-1B. Please ensure your response addresses any changes to your plans subsequent to Venator’s IPO and address the guidance in ASC 205-20-45-1E.f. Also, explain the extent of your involvement in Venator’s operations subsequent to it's IPO and subsequent to your deconsolidation. Finally, address your intentions with regard to the time frame of your continued involvement and explain how you contemplated the guidance in ASC 20520-45-1E.e. In this regard, we note from your earnings calls that the determination to sell your remaining interest is dependent on the future stock price of Venator.

HUN answered
to the Staff’s comment, we respectfully note that beginning in December 2018 we deconsolidated Venator Materials PLC (“Venator”) and thereafter recorded our remaining 49% interest in Venator as an equity method investment reported in continuing operations, rather than discontinued operations. Furthermore, we acknowledge the Staff’s comments and provide our responses below.

Beginning in the third quarter of 2017, we separated Venator, our former Pigments and Additives business, and conducted an IPO of ordinary shares of Venator.
Rest of the answer

Prior to the separation, Venator was comprised of operations and cash flows that were clearly distinguished, operationally and for financial reporting purposes, from the rest of our businesses. Therefore, Venator, formerly its own reportable operating segment of Huntsman, constituted a component for purposes of evaluating held for sale and discontinued operations criteria. Management had approved the action and committed to a plan to sell Venator and actively marketed the shares of Venator at a reasonable price in relation to its then current fair value. In the third quarter of 2017, we concluded that the assets and liabilities of Venator met all the criteria for held for sale accounting and reporting.

In response to the Staff’s comments, in the third quarter of 2017, we concluded that all criteria for discontinued operations had also been met, and we began to report the results of operations of Venator as discontinued operations in our Form 10-Q for the quarterly period ended September 30, 2017. Our global strategy for significant value creation through the year 2020, as noted in our May 23, 2018 Investor Day presentation, includes the monetization of our remaining Venator shares and increased capital allocation for growth in our downstream portfolio. Consistent with this global strategy, the separation of Venator represented a strategic shift that had a major effect on our operations and financial results, particularly as the separation was a disposal of all of our former Pigments and Additives business and an entire reportable operating segment. We are no longer a participant in the titanium oxide, functional additives, color pigments and timber and water treatment markets, where historically we had been a significant market participant. Notwithstanding our remaining ownership in Venator, the separation plan has always been to have Venator operate as an independent entity and for us to not retain a controlling interest.

Subsequent to the separation of Venator, aside from our remaining ownership in Venator ordinary shares, our current retained equity method investment in Venator and a transition services agreement with Venator for a limited period of time, we have not had any significant continuing involvement with Venator, such as supply chain and distribution agreements, financial guarantees, nor options to repurchase any assets of Venator. Additionally, since the separation, our role has been passive, and we have not had any management nor corporate oversight of Venator as it has been under its own management and has operated as an independent entity beginning in the third quarter of 2017. We maintain that Venator’s Board of Directors has been independently comprised. While three of the six current members also serve on the Huntsman Board, this does not prevent us from concluding that we do not have significant continuing involvement; the overall composition of the Venator Board is independent of management of the Companies. In the third quarter of 2017, we entered into a transition services agreement to provide certain administrative services through the end of July 2019. Based on all the above, we concluded that we have not had any significant continuing involvement in Venator subsequent to the separation and IPO of Venator in the third quarter of 2017.

Following the Venator IPO, we retained approximately 75% ownership in Venator with the intention to monetize our retained ownership in Venator at prevailing market conditions, either through follow-on multiple capital market or block transactions to permit the orderly distribution of our retained shares. In accordance with these plans, we conducted a secondary offering in December 2017, and along with the underwriters’ purchase of additional shares of Venator, our ownership interest in Venator reduced to 53%. Through 2018, we continued to actively market our retained ownership in Venator at a reasonable price. In December 2018, we sold an additional 4% of Venator ordinary shares, which resulted in deconsolidation of Venator beginning in December 2018, as we no longer had a controlling financial interest in the entity. We did not consider any of these events as significant changes to our original plan. In accordance with ASC 810, the deconsolidation event is accounted for as if we had disposed of all our interest in Venator and then acquired the 49% retained interest. Thus, we initially recognized, at fair value, the retained 49% interest in Venator as an equity method investment and elected to subsequently account for the investment under the fair value option reflected in continuing operations as holders of an investment available to be monetized.

At the present time, there is no change in management’s commitment and plan to sell our remaining ownership interest in Venator. However, although we intend to monetize our remaining 49% ownership in Venator, as the Staff has noted from our earnings calls, the determination to sell our remaining interest is dependent on the future stock performance of Venator. At the present time, the depressed Venator stock price inhibits our ability to sell our remaining shares of Venator at a reasonable price, which could continue for more than twelve months. As such, since the deconsolidation of Venator, our equity method investment in Venator did not meet the held for sale criteria and, in turn, discontinued operations criteria, and our equity method investment in Venator is recorded in continuing operations. We have included the following disclosure in “Note 4. Business Dispositions” to our condensed consolidated financial statements for the quarterly period ended June 30, 2019:

“Although we intend to monetize our remaining 49% ownership in Venator, our ability to sell our ordinary shares of Venator at a reasonable price is dependent upon the prevailing market value of Venator common stock. The depressed Venator stock price inhibits our ability to sell our remaining shares of Venator at a reasonable price, which could continue for more than twelve months. Therefore, in December 2018, our equity method investment in Venator did not meet the held for sale criteria and our equity method investment in Venator was recorded in continuing operations.”

Read in the reply
In its next report

First report after the company's reply of Aug 9, 2019: 10-Q filed Oct 25, 2019 ↗, against the 10-Q filed Apr 30, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Form 10-Q for the Quarterly Period Ended March 31, 2019 · Note 4. Discontinued Operations and Business Dispositions, page 20
SEC asked (2)
We note that the $75 million fair value adjustment to your investment in Venator appears material to your results of operations. Please tell us what consideration was given to providing the disclosures required by Rule 4-08(g) of Regulation S-X for this investment.
Rest of the question

In this regard, we believe that the income test set forth in Rule 1-02(w) should be computed using as the numerator the change in the fair value reflected in your income statement rather than the equity in earnings of the investee.

HUN answered
to the Staff’s comment, we performed the interim analysis for the three months ended March 31, 2019 using the guidance provided by Rule 10-01(b)(1). We acknowledge the Staff’s comment regarding the assessment required by Rule 4-08(g) and note that for annual filings the guidance around the numerator is clear in accordance with Financial Reporting Manual (“FRM”) section 2435. We further note that the guidance around the numerator for the annual test is not clearly linked to the guidance provided for interim assessments under Rule 10-01(b)(1) as noted in FRM section 2420.7.
Rest of the answer

Notwithstanding, we acknowledge the Staff’s comment that the annual and interim guidance should be linked, and for future interim filings commencing with the six months ended June 30, 2019 we will utilize the change in fair value of our investment in Venator as the numerator for the income test.

None of the significance tests, including the income test using the change in fair value of our investment in Venator as the numerator, were met for the six months ended June 30, 2019. Using the change in fair value of our investment in Venator as the numerator, the income test would have been met for the three months ended March 31, 2019. We determined that the summarized income statement information for Venator for the three months ended March 31, 2019 was neither meaningful nor material to our condensed consolidated financial statements. For the three months ended March 31, 2018, Venator was consolidated in our condensed consolidated financial statements.

As noted, we account for our remaining investment in Venator as an equity method investment using the fair value option. We adjust our investment in Venator to market at the end of every month using the closing market value of Venator at the closest trading day to the end of the month. Venator’s stock price is subject to volatility, which impacts the results of the significant subsidiary test from quarter to quarter. Our investment value in Venator is based solely on the market price at the end of each month with no regard to any of the financial metrics that are required by the summarized disclosures. We believe that the fair market value adjustment amount disclosed on the face of our financial statements and discussed in “Note 4. Business Dispositions” to our condensed consolidated financial statements provides the best information to users of our financial statements.

We also note that Venator is a publicly traded company, and all relevant financial information is readily available in its filings with the SEC on a quarterly basis. We will continue to utilize the change in fair value of our investment in Venator as the numerator for the income test for future filings. As such, in the periods where a significance test is met, we will assess if the required disclosure becomes meaningful to our consolidated financial statements.

Read in the reply
In its next report

First report after the company's reply of Aug 9, 2019: 10-Q filed Oct 25, 2019 ↗, against the 10-Q filed Apr 30, 2019 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2019-08-29

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 10 letters filed since 2019-07-26. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HUN/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.